On Wednesday, October 2, 2019, the American Antitrust Institute will host a competition roundtable “Stemming the Tide of Anti-Competitive Harm in Pharmaceuticals” at the National Press Club in Washington, D.C.
The roundtable will take up competition enforcement and policy issues involving the pharmaceutical industry, their major impact on the healthcare system and on consumers, and policy prescriptions for improving competition. Experts in antitrust and regulation from government, industry, advocacy, and academia will frame major competitive issues through the lens of different stakeholder and enforcement perspectives.
- Bradley S. Albert, Deputy Assistant Director, Health Care, Federal Trade Commission
- Shannon Curtis, Assistant Director of Federal Affairs, American Medical Association
- Daniel E. Gustafson, Founding Member, Gustafson Gluek PLLC
- Cheryl Johnson, Deputy Attorney General, California Department of Justice
- Michael Kades, Director for Markets and Competition Policy. Washington Center for Equitable Growth
- Amanda Lewis, Counsel-Detailee, Subcommittee on Antitrust, Commercial, and Administrative Law, U.S. House Committee on the Judiciary
- Diana Moss, President, American Antitrust Institute
- Amanda P. Reeves, Partner, Latham & Watkins LLP
- Steve Shadowen, Founding Partner, Hilliard & Shadowen